Diebold Nixdorf: Nothing That Turns The Eye
Source: SeekingAlpha
2026-07-10 12:44:42 ET
Investment Thesis
Shares of Diebold Nixdorf ( DBD ) have been on a surge over the past 12 months, up 42.86%. This comes at a time when management is providing some pretty decent guidance numbers for FY2026, including a midpoint of $265 million in free cash flows. With a market cap sitting at $2.94 billion, this implies a pretty cheap P/FCF when the sector median sits at 19.2x....
Read the full article on Seeking Alpha
For further details see:
Diebold Nixdorf: Nothing That Turns The Eye
Diebold Nixdorf Incorporated
NASDAQ: DBD
DBD Trading
5.71% G/L:
$66.745 Last:
167,557 Volume:
$63.77 Open:
DBD Latest News
May 28, 2026 08:15:00 am
Diebold Nixdorf to Participate in D.A. Davidson Technology and Consumer Conference
$2,581,538,553
35,867,156
16.93%
50
N/A
Software & IT Services
Technology
US
North Canton
